Fintel reports that on January 10, 2025, Piper Sandler initiated coverage of ResMed (NYSE:RMD) with a Neutral recommendation.
"'The market environment will likely become a bit more difficult in the coming week, as supply will jump to its highest level ...
Fintel on MSN19h
Piper Sandler Upgrades NIKE (NKE)Fintel reports that on January 10, 2025, Piper Sandler upgraded their outlook for NIKE (NYSE:NKE) from Neutral to Overweight.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback